Search Results for 'Ldl Heart'

Ldl Heart published presentations and documents on DocSlides.

Abnormalities of LDL metabolism
Abnormalities of LDL metabolism
by briana-ranney
Physiology, pathophysiology and treatments. Under...
Is lower better? LDL targets and beyond.
Is lower better? LDL targets and beyond.
by trish-goza
Implications of the relationship between risk fac...
Looking to FOURIER:  What do the trials tell us about LDL lowering and cardiovascular events?
Looking to FOURIER: What do the trials tell us about LDL lowering and cardiovascular events?
by min-jolicoeur
NICE –CG 181 Continuum of CVD Risk and its trea...
Is lower better? LDL targets and beyond.
Is lower better? LDL targets and beyond.
by olivia-moreira
Implications of the relationship between risk fac...
LDL  Apheresis  in Drug Resistant Nephrotic Syndrome
LDL Apheresis in Drug Resistant Nephrotic Syndrome
by obrien
Rodney D Gilbert. Patient JM. 14 year old girl, pr...
PCSK9 Inhibition: LDL Lowering
PCSK9 Inhibition: LDL Lowering
by SweetiePie
PCSK9 inhibitors. New option for dyslipidemia. Ali...
Residual risk: Is LDL target enough?
Residual risk: Is LDL target enough?
by candy
An interpretation of the continuous relationship b...
New Insights in
New Insights in
by yoshiko-marsland
the Understanding . of . Cholesterol Metabolism:....
Cholesterol and C.V.D.
Cholesterol and C.V.D.
by sherrill-nordquist
Learning outcome. Most cholesterol is synthesised...
Genetic Variants of Proprotein Convertase Subtilisin/Kexin
Genetic Variants of Proprotein Convertase Subtilisin/Kexin
by mitsue-stanley
Type 9 (PCSK9). Implications for Low-Density Lipo...
DIABETES  AND  LIPID
DIABETES AND LIPID
by yoshiko-marsland
S-KHALILZADEH. Lipids are hydrophobic molecules t...
The State of
The State of
by olivia-moreira
Dyslipidemia. . Treatment. USA-145-101385. © . ...
Novel therapies for the prevention of atherosclerotic vascu
Novel therapies for the prevention of atherosclerotic vascu
by debby-jeon
Prof. . John . Kastelein. Academic Medical Centre...
Advancing the Understanding
Advancing the Understanding
by briana-ranney
of Cholesterol Metabolism:. The Role of . Proprot...
Familial
Familial
by sherrill-nordquist
Hypercholesterolaemia. . N. ew local pathways. D...
Familial Hypercholesterolemia
Familial Hypercholesterolemia
by faustina-dinatale
KEY POINTS . FH is an autosomal dominant genetic...
Plant stanol ester in the treatment and prevention guidelin
Plant stanol ester in the treatment and prevention guidelin
by stefany-barnette
0. International Atherosclerosis Society, 2013. A...
KA  7d
KA 7d
by olivia-moreira
: Learning Outcomes. State where cholesterol is s...
Familial Hypercholesterolemia
Familial Hypercholesterolemia
by pasty-toler
Developed by . Ms. . Shawna . Morrison, Dr. Judit...
Lipid Metabolism
Lipid Metabolism
by kittie-lecroy
Chapter 29, . Stryer. Short Course. Lipid anabol...
Understanding Blood Lipids
Understanding Blood Lipids
by myesha-ticknor
and Their Relationship to Health. Mark Pettus MD...
Cholesterol Treatment Trialists’ (CTT) Collaboration
Cholesterol Treatment Trialists’ (CTT) Collaboration
by briana-ranney
Slide deck. CTT Collaboration: Background*. Histo...
Triglycerides and Risk for Atherothrombosis
Triglycerides and Risk for Atherothrombosis
by briana-ranney
Thomas Dayspring, MD, FACP. Clinical Assistant Pr...
FOURIER F urther cardiovascular
FOURIER F urther cardiovascular
by trish-goza
OU. tcomes. . R. esearch with PCSK9 . I. nhibiti...
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
by pamella-moone
Hyperlipidemic. Subjects: A 52 Week Phase 3 Dou...
HOT TOPICS IN CHOLESTEROL
HOT TOPICS IN CHOLESTEROL
by tatyana-admore
Are Statins as Effective in Women as in Men? Upda...
American Association of Clinical Endocrinologists and American College of Endocrinology
American Association of Clinical Endocrinologists and American College of Endocrinology
by natalia-silvester
Guidelines for Management of Dyslipidemia . and P...
Update:  Lipid Guidelines
Update: Lipid Guidelines
by yoshiko-marsland
DO NOT BURN THE COOKIES. Amy R. Woods, M.D.. a. ...
Cholesterol-Lowering Drugs
Cholesterol-Lowering Drugs
by cheryl-pisano
Victor Nadler. Objectives. By the end of this cla...
The Importance of Potential
The Importance of Potential
by pamella-moone
Statin. in High Risk Patient. Masrul Syafri. Bag...
Management of Common Comorbidities in Diabetes
Management of Common Comorbidities in Diabetes
by celsa-spraggs
1. Obesity. Management of Common Comorbidities in...
Fat Nutrition 2102 https://www.youtube.com/watch?v=yWDgf7w6Zw0
Fat Nutrition 2102 https://www.youtube.com/watch?v=yWDgf7w6Zw0
by kittie-lecroy
http://video.about.com/lowfatcooking/Overview-of-...
New developments in lipid management
New developments in lipid management
by pasty-toler
CGR 0800 h 11 May 2015. Rob Hegele MD FRCPC FACP....
Trial Design Evolocumab SC
Trial Design Evolocumab SC
by danika-pritchard
140 mg Q2W or 420 mg QM. Placebo SC. Q2W or QM. L...
LSU Journal Club Efficacy and Safety of
LSU Journal Club Efficacy and Safety of
by trish-goza
Evolocumab. in. Reducing Lipids and Cardiovascul...
PCSK-9 Inhibitors Paul J
PCSK-9 Inhibitors Paul J
by tatyana-admore
PCSK-9 Inhibitors Paul J Kovack , DO, FACC, FACO...
 Cholesterol metabolism Biological significance of cholesterol
Cholesterol metabolism Biological significance of cholesterol
by alida-meadow
Cholesterol is an essential lipid constituent of ...
 Diabetes and Dyslipidemia
Diabetes and Dyslipidemia
by danika-pritchard
2013 ACC/AHA Guideline on the. Treatment of Blood...
HYPERLIPIDAEMIAS Dr.D.Rispa
HYPERLIPIDAEMIAS Dr.D.Rispa
by kaptainpositive
Assistant Professor. Pharmacy Practice Department....
About OMICS Group
About OMICS Group
by hirook
. OMICS Group is an amalgamation of . Open Access...